- Home
- EOD vs INMB Comparison
EOD vs INMB Comparison
Compare EOD & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EOD
- INMB
- Stock Information
- Founded
- EOD 2007
- INMB 2015
- Country
- EOD United States
- INMB United States
- Employees
- EOD N/A
- INMB N/A
- Industry
- EOD Investment Managers
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- EOD Finance
- INMB Health Care
- Exchange
- EOD Nasdaq
- INMB Nasdaq
- Market Cap
- EOD 213.8M
- INMB 176.5M
- IPO Year
- EOD N/A
- INMB 2019
- Fundamental
- Price
- EOD $5.29
- INMB $7.27
- Analyst Decision
- EOD
- INMB Strong Buy
- Analyst Count
- EOD 0
- INMB 3
- Target Price
- EOD N/A
- INMB $24.33
- AVG Volume (30 Days)
- EOD 118.1K
- INMB 285.1K
- Earning Date
- EOD 01-01-0001
- INMB 05-08-2025
- Dividend Yield
- EOD 9.28%
- INMB N/A
- EPS Growth
- EOD N/A
- INMB N/A
- EPS
- EOD N/A
- INMB N/A
- Revenue
- EOD N/A
- INMB $50,000.00
- Revenue This Year
- EOD N/A
- INMB N/A
- Revenue Next Year
- EOD N/A
- INMB $43,178.43
- P/E Ratio
- EOD N/A
- INMB N/A
- Revenue Growth
- EOD N/A
- INMB N/A
- 52 Week Low
- EOD $3.73
- INMB $4.32
- 52 Week High
- EOD $4.71
- INMB $10.50
- Technical
- Relative Strength Index (RSI)
- EOD 61.72
- INMB 46.09
- Support Level
- EOD $5.16
- INMB $7.25
- Resistance Level
- EOD $5.30
- INMB $8.06
- Average True Range (ATR)
- EOD 0.07
- INMB 0.45
- MACD
- EOD -0.00
- INMB -0.03
- Stochastic Oscillator
- EOD 93.75
- INMB 21.85
About EOD Allspring Global Dividend Opportunity Fund of Beneficial Interest
Allspring Global Dividend Opportunity Fund is a diversified closed-end management investment company. Its primary investment objective is to seek a high level of current income. The fund's secondary objective is the long-term growth of capital. The fund allocates its assets between two separate investment strategies or sleeves. Under normal market conditions, the fund allocates approximately 80% of its total assets to an equity sleeve comprised of common stocks.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.